The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA Peptide Reclassification 2026: What It Means for Providers A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides